Cost-effectiveness of universal influenza vaccination in a pregnant population.
OBJECTIVE
The purpose of this study was to estimate whether universal influenza vaccination of pregnant women was cost-effective in the management of influenza-like illness during influenza season.


METHODS
A decision analysis model was developed to investigate the cost-effectiveness of providing inactivated trivalent influenza vaccine to all pregnant women. This scenario was compared with providing supportive care only on a case-by-case basis to the unvaccinated pregnant population.


RESULTS
Vaccination of 100% of pregnant women would save approximately 50 dollars per woman, resulting in a net gain of approximately 45 quality-adjusted hours relative to providing supportive care only.


CONCLUSIONS
Universal vaccination with inactivated trivalent influenza vaccine is cost-saving relative to providing supportive care alone in the pregnant population.


METHODS
III.
Roberts
Scott
S
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9032, USA scott.roberts@utsouthwestern.edu
Hollier
Lisa M
LM
Sheffield
Jeanne
J
Laibl
Vanessa
V
Wendel
George D
GD
D000293:Adolescent; D000328:Adult; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000191:economics*; D007252:Influenza Vaccines / Q000191:economics* / Q000600:supply & distribution; D007251:Influenza, Human / Q000191:economics / Q000517:prevention & control*; D009010:Monte Carlo Method; D009975:Orthomyxoviridae / Q000276:immunology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000191:economics / Q000517:prevention & control*; D019057:Quality-Adjusted Life Years
D007252:Influenza Vaccines